McDaniel Mims B, Furr K, Enriquez J, Grisham M
Dis Model Mech. 2025; 18(2).
PMID: 40019007
PMC: 11892683.
DOI: 10.1242/dmm.052084.
Lana J, de Brito G, Kruel A, Brito B, Santos G, Caliari C
Bioengineering (Basel). 2024; 11(10).
PMID: 39451354
PMC: 11504458.
DOI: 10.3390/bioengineering11100979.
Gluckman E, Sureda A
Bone Marrow Transplant. 2024; 59(10):1341-1348.
PMID: 39095547
PMC: 11452336.
DOI: 10.1038/s41409-024-02366-4.
Denk A, Edinger M, Weber D, Holler E, Fante M, Meedt E
Ann Hematol. 2024; 103(8):3071-3081.
PMID: 38916740
PMC: 11283387.
DOI: 10.1007/s00277-024-05696-x.
Tao Y, Luo C, Zhang B, Shen X, Zhao R, Ma B
World J Pediatr. 2024; 20(9):966-975.
PMID: 38367140
PMC: 11422252.
DOI: 10.1007/s12519-023-00776-w.
Galectin-9 alleviates acute graft-versus-host disease after haplo-hematopoietic stem cell transplantation by regulating regulatory T cell/effector T cell imbalance.
Pang N, Tudahong S, Zhu Y, He J, Han C, Chen G
Immun Inflamm Dis. 2024; 12(2):e1177.
PMID: 38353382
PMC: 10865418.
DOI: 10.1002/iid3.1177.
The clinical outcomes of haploidentical stem cell transplantation (haplo-HSCT) for patients with therapy-related myelodysplastic syndrome: comparable to de novo myelodysplastic syndrome.
Tang F, Wang Y, Wang Y, Jin J, Han W, Chen Y
Clin Exp Med. 2024; 24(1):33.
PMID: 38329593
PMC: 10853308.
DOI: 10.1007/s10238-023-01287-8.
The level of Tim-3+CD8+ T cells can serve as a potential marker for evaluating the severity of acute graft-versus-host disease after haplo-PBSCT.
Pang N, Yu M, Xu J, Yuan H, Chen G, Wang D
Braz J Med Biol Res. 2023; 56:e12997.
PMID: 38126537
PMC: 10729645.
DOI: 10.1590/1414-431X2023e12997.
Proactive enteral nutrition for patients undergoing allogeneic stem cell transplantation- implementation and clinical outcomes.
Andersen S, Fichera R, Banks M, Brown T, Kennedy G, Weber N
Eur J Clin Nutr. 2023; 78(3):251-256.
PMID: 37968417
DOI: 10.1038/s41430-023-01367-8.
The salvage role of allogeneic hematopoietic stem-cell transplantation in relapsed/refractory diffuse large B cell lymphoma.
Min G, Jeon Y, Kim T, Kwag D, Kim B, Lee J
Sci Rep. 2023; 13(1):17496.
PMID: 37840059
PMC: 10577125.
DOI: 10.1038/s41598-023-44241-0.
Lower overall survival in male patients with advanced disease undergoing allogeneic hematopoietic stem cell transplantation is associated with Leu432Val polymorphism.
Stute N, Koldehoff M
Haematologica. 2023; 109(3):799-808.
PMID: 37767566
PMC: 10905095.
DOI: 10.3324/haematol.2023.283649.
Salvage hematopoietic stem cell transplantation for patients with higher leukemia burden in relapsed or refractory acute myeloid leukemia: a ten-year study.
Jiang S, Lu X, Wei R, Zhang A, Chen H, Shi W
Ann Hematol. 2023; 102(11):3205-3216.
PMID: 37682324
DOI: 10.1007/s00277-023-05406-z.
Nutrition support and clinical outcomes following allogeneic stem cell transplantation.
Andersen S, Xu J, Llewellyn S, Kennedy G, Bauer J
Bone Marrow Transplant. 2023; 58(10):1137-1142.
PMID: 37542189
DOI: 10.1038/s41409-023-02080-7.
New Perspectives on Primary Prophylaxis of Invasive Fungal Infection in Children Undergoing Hematopoietic Stem Cell Transplantation: A 10-Year Retrospective Cohort Study.
Ricard N, Zebali L, Renard C, Goutagny M, Benezech S, Bertrand Y
Cancers (Basel). 2023; 15(7).
PMID: 37046769
PMC: 10093632.
DOI: 10.3390/cancers15072107.
Comparison of efficacies of haploidentical transplantation and matched sibling donor transplantation in treating T-cell lymphoblastic lymphoma.
Wei R, Fang J, Shi W, Lu X, Wu Y, Jiang S
Cancer Med. 2023; 12(9):10499-10511.
PMID: 36992548
PMC: 10225212.
DOI: 10.1002/cam4.5786.
Optimized therapeutic strategy for patients with refractory or relapsed acute myeloid leukemia: long-term clinical outcomes and health-related quality of life assessment.
Yan C, Wang Y, Sun Y, Cheng Y, Mo X, Wang F
Cancer Commun (Lond). 2022; 42(12):1387-1402.
PMID: 36274263
PMC: 9759766.
DOI: 10.1002/cac2.12376.
Preclinical validation and treatment of volumetric modulated arc therapy based total bone marrow irradiation in Halcyon™ ring gantry linear accelerator.
Shahid T, Mandal S, Biswal S, De A, Mukherjee M, Roy Chowdhury S
Radiat Oncol. 2022; 17(1):145.
PMID: 35986327
PMC: 9389791.
DOI: 10.1186/s13014-022-02109-z.
Effects of Soy-Whey Protein Nutritional Supplementation on Hematopoiesis and Immune Reconstitution in an Allogeneic Transplanted Mice.
Wu X, Hou Q, Zhao Z, Wang J, Guo Y, Lu L
Nutrients. 2022; 14(15).
PMID: 35893870
PMC: 9332233.
DOI: 10.3390/nu14153014.
Chimeric Antigen Receptor T Cell Therapy versus Hematopoietic Stem Cell Transplantation: An Evolving Perspective.
Goldsmith S, Ghobadi A, Dipersio J, Hill B, Shadman M, Jain T
Transplant Cell Ther. 2022; 28(11):727-736.
PMID: 35878743
PMC: 10487280.
DOI: 10.1016/j.jtct.2022.07.015.
Oral eltrombopag versus subcutaneous recombinant human thrombopoietin for promoting platelet engraftment after allogeneic stem cell transplantation: A prospective, non-inferiority, randomized controlled trial.
Wen B, Zhang X, Chen S, Fan J, Yang S, Cai Y
Hematol Oncol. 2022; 40(4):777-786.
PMID: 35554955
PMC: 9790607.
DOI: 10.1002/hon.3017.
